KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Shares Outstanding (Weighted Average): 2010-2025

Historic Shares Outstanding (Weighted Average) for Pacira BioSciences (PCRX) over the last 16 years, with Sep 2025 value amounting to $44.9 million.

  • Pacira BioSciences' Shares Outstanding (Weighted Average) fell 2.59% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.9 million, marking a year-over-year decrease of 2.59%. This contributed to the annual value of $46.2 million for FY2024, which is 0.57% down from last year.
  • As of Q3 2025, Pacira BioSciences' Shares Outstanding (Weighted Average) stood at $44.9 million, which was down 2.96% from $46.3 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Shares Outstanding (Weighted Average) peaked at $46.5 million during Q2 2024, and registered a low of $43.9 million during Q1 2021.
  • Over the past 3 years, Pacira BioSciences' median Shares Outstanding (Weighted Average) value was $46.3 million (recorded in 2025), while the average stood at $46.2 million.
  • As far as peak fluctuations go, Pacira BioSciences' Shares Outstanding (Weighted Average) increased by 4.52% in 2021, and later fell by 2.59% in 2025.
  • Over the past 5 years, Pacira BioSciences' Shares Outstanding (Weighted Average) (Quarterly) stood at $44.5 million in 2021, then climbed by 3.00% to $45.9 million in 2022, then rose by 1.21% to $46.4 million in 2023, then declined by 0.57% to $46.2 million in 2024, then declined by 2.59% to $44.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $44.9 million in Q3 2025, compared to $46.3 million in Q2 2025 and $46.3 million in Q1 2025.